Medgenics (MDGN) Reports Q4 Loss of $0.30/Share

Medgenics (NYSE: MDGN) reported Q4 EPS of ($0.30), versus ($0.28) reported last year.

For earnings history and earnings-related data on Medgenics (MDGN) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
• Change in Nonfarm Payrolls (Sep) 29K vs 90K Expected, Unemployment Rate 4.2%